Recombinant Antibodies against Mycolactone

Area of Science:

• Immunology
• Microbiology
• Biotechnology

Background:

• Mycolactone, the primary lipidic toxin of Mycobacterium ulcerans, causes Buruli ulcer.
• Generating antibodies against mycolactone has been challenging due to its immunosuppressive properties.
• Traditional immunization methods are difficult for toxins like mycolactone unless structurally modified.

Purpose of the Study:

• To investigate the utility of in vitro display methods for antibody generation against mycolactone.
• To select and identify antibodies that recognize mycolactone from a large antibody library.

Main Methods:

• Utilized in vitro display techniques, specifically phage and yeast display.
• Screened a large human naïve phage antibody library for mycolactone-specific antibodies.

Main Results:

• Successfully isolated ten different antibodies recognizing mycolactone.
• Identified hundreds of additional antibodies using next-generation sequencing.
• Demonstrated the efficacy of in vitro display for targeting difficult antigens.

Conclusions:

• In vitro display is a valuable method for generating antibodies against immunosuppressive toxins like mycolactone.
• The generated anti-mycolactone antibodies offer potential for developing rapid diagnostic and detection methods for Buruli ulcer.